Alnylam Pharmaceuticals Inc (ALNY)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$399.92

Buy

$402.10

arrow-up$4.97 (+1.25%)

Prices updated at 19 Dec 2025, 14:33 EST

Prices minimum 15 mins delay

Prices in USD

Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.

NASDAQ

0.68%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$401.90 - $396.06
	$495.55 - $205.87
	-
	52,322.36m
	1,320.13
	-
	17,465
	223.70
	1,001,810.59
	1.05
	129.29m
	US02043Q1076
	0.30
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.